We assessed the chimerism of CD34+ bone marrow cells before donor leukocyte infusion
(DLI) on nine occasions in seven patients with leukemic relapse after allogeneic marrow …

Donor lymphocyte infusions (DLI) have been shown to enhance the graft-versus-leukaemia
(GVL) effect and induce haematological and molecular remission in patients with relapsed …

We conducted 2 sequential studies of donor leukocyte infusion (DLI) in 26 patients with
chronic myeloid leukemia in hematologic relapse after unmodified allogeneic bone marrow …

PURPOSE Treatment options for patients with chronic myeloid leukemia (CML) who relapse
after allogeneic bone marrow transplantation (BMT) are limited. Treatment with lymphocytes …

Allogeneic bone marrow transplantation is an effective treatment of leukemia. Intensive
chemo‐and radiotherapy used for conditioning and T‐cells of the graft contribute to the …

Donor leukocyte infusions were administered to a patient who had relapsed with chronic
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …

A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …

To clarify the role of donor leukocyte infusion (DLI) in the treatment of leukemia relapsing
after allo-BMT, data from 100 patients were collected from 46 facilities in Japan and …

A total of 243 patients with acute leukemia received a marrow graft from a donor of the
opposite sex. Seventy-five patients subsequently relapsed, and specimens of the recurrent …

Donor lymphocyte infusions (DLI) were given between June 1990 and March 1996 to 18
patients with chronic myeloid leukemia (CML) for the treatment of cytogenetic (n= 6) or …